FIRSTSTEPDX Trademark

Trademark Overview

On Wednesday, July 28, 2010, a trademark application was filed for FIRSTSTEPDX with the United States Patent and Trademark Office. The USPTO has given the FIRSTSTEPDX trademark a serial number of 85095105. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, October 4, 2022. This trademark is owned by LineaGen, Inc.. The FIRSTSTEPDX trademark is filed in the Medical Instrument Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical testing services, namely, molecular and genetic testing for disorders of childhood development

Medical specimen collection and transportation kit comprised of blood collection tubes, foam container for tubes, absorbent pad, biohazard bag, marker, labels, mail packaging, forms and instructions, for molecular and genetic testing for disorders of childhood development
firststepdx

General Information

Serial Number85095105
Word MarkFIRSTSTEPDX
Filing DateWednesday, July 28, 2010
Status800 - REGISTERED AND RENEWED
Status DateTuesday, October 4, 2022
Registration Number4039525
Registration DateTuesday, October 11, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2011

Trademark Statements

Pseudo MarkFIRST STEP DX
Goods and ServicesMedical testing services, namely, molecular and genetic testing for disorders of childhood development
Goods and ServicesMedical specimen collection and transportation kit comprised of blood collection tubes, foam container for tubes, absorbent pad, biohazard bag, marker, labels, mail packaging, forms and instructions, for molecular and genetic testing for disorders of childhood development

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, August 2, 2010
Primary Code010
First Use Anywhere DateMonday, January 31, 2011
First Use In Commerce DateMonday, January 31, 2011
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 2, 2010
Primary Code044
First Use Anywhere DateMonday, January 31, 2011
First Use In Commerce DateMonday, January 31, 2011

Trademark Owner History

Party NameLineaGen, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108
Party NameLineaGen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108
Party NameLineaGen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108

Trademark Events

Event DateEvent Description
Wednesday, October 18, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, October 4, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, October 4, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, October 4, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, October 4, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 8, 2022TEAS SECTION 8 & 9 RECEIVED
Thursday, June 17, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 17, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 17, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 17, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 17, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, October 11, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, January 30, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, January 30, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, January 30, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, November 17, 2016TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 11, 2011REGISTERED-PRINCIPAL REGISTER
Thursday, September 8, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 7, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, September 1, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 23, 2011STATEMENT OF USE PROCESSING COMPLETE
Friday, August 5, 2011USE AMENDMENT FILED
Monday, August 22, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 5, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, May 10, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 15, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 15, 2011PUBLISHED FOR OPPOSITION
Thursday, February 10, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 4, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 4, 2011EXAMINER'S AMENDMENT ENTERED
Friday, February 4, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 4, 2011EXAMINERS AMENDMENT E-MAILED
Friday, February 4, 2011EXAMINERS AMENDMENT -WRITTEN
Monday, January 31, 2011PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, January 7, 2011WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, December 27, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 27, 2010ASSIGNED TO LIE
Friday, December 3, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 3, 2010EXAMINER'S AMENDMENT ENTERED
Friday, December 3, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 3, 2010EXAMINERS AMENDMENT E-MAILED
Friday, December 3, 2010EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 10, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 10, 2010NON-FINAL ACTION E-MAILED
Wednesday, November 10, 2010NON-FINAL ACTION WRITTEN
Wednesday, November 10, 2010ASSIGNED TO EXAMINER
Tuesday, August 3, 2010NOTICE OF PSEUDO MARK MAILED
Monday, August 2, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 31, 2010NEW APPLICATION ENTERED

Related Keywords

firststepdx testing childhood collection tubes disorders medical development molecular genetic instructions